Topical cyclosporine in high-risk corneal transplants

Michael W Belin, C. S. Bouchard, S. Frantz, J. Chmielinska

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

Cyclosporine (cyclosporin A, CsA) is a selective T-cell immunosuppressant that works primarily through inhibition of both antigen presentation and lymphokine production. It has dramatically improved the prognosis for solid organ transplantation. Significant nephrotoxicity has been associated with its systemic use. Topical CsA 2% was used in 11 high-risk corneal transplant patients (8 men; 3 women; average age, 44 years). Ten (91%) of 11 corneas remained clear at an average follow-up of 16 months (range, 6-24 months). All patients had transient epithelial keratitis. Systemic whole blood levels of CsA measured by high-performance liquid chromatography (HPLC) ranged from 14 to 64 ng/ml. All previous reports on the use of topical CsA in high-risk corneal transplant patients have not detected systemic CsA levels.

Original languageEnglish (US)
Pages (from-to)1144-1150
Number of pages7
JournalOphthalmology
Volume96
Issue number8
StatePublished - 1989
Externally publishedYes

Fingerprint

Cyclosporine
Transplants
Keratitis
Lymphokines
Antigen Presentation
Organ Transplantation
Immunosuppressive Agents
Cornea
High Pressure Liquid Chromatography
T-Lymphocytes

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Belin, M. W., Bouchard, C. S., Frantz, S., & Chmielinska, J. (1989). Topical cyclosporine in high-risk corneal transplants. Ophthalmology, 96(8), 1144-1150.

Topical cyclosporine in high-risk corneal transplants. / Belin, Michael W; Bouchard, C. S.; Frantz, S.; Chmielinska, J.

In: Ophthalmology, Vol. 96, No. 8, 1989, p. 1144-1150.

Research output: Contribution to journalArticle

Belin, MW, Bouchard, CS, Frantz, S & Chmielinska, J 1989, 'Topical cyclosporine in high-risk corneal transplants', Ophthalmology, vol. 96, no. 8, pp. 1144-1150.
Belin MW, Bouchard CS, Frantz S, Chmielinska J. Topical cyclosporine in high-risk corneal transplants. Ophthalmology. 1989;96(8):1144-1150.
Belin, Michael W ; Bouchard, C. S. ; Frantz, S. ; Chmielinska, J. / Topical cyclosporine in high-risk corneal transplants. In: Ophthalmology. 1989 ; Vol. 96, No. 8. pp. 1144-1150.
@article{aa3ab0fef1a24b9ba5c05ca179cddc3c,
title = "Topical cyclosporine in high-risk corneal transplants",
abstract = "Cyclosporine (cyclosporin A, CsA) is a selective T-cell immunosuppressant that works primarily through inhibition of both antigen presentation and lymphokine production. It has dramatically improved the prognosis for solid organ transplantation. Significant nephrotoxicity has been associated with its systemic use. Topical CsA 2{\%} was used in 11 high-risk corneal transplant patients (8 men; 3 women; average age, 44 years). Ten (91{\%}) of 11 corneas remained clear at an average follow-up of 16 months (range, 6-24 months). All patients had transient epithelial keratitis. Systemic whole blood levels of CsA measured by high-performance liquid chromatography (HPLC) ranged from 14 to 64 ng/ml. All previous reports on the use of topical CsA in high-risk corneal transplant patients have not detected systemic CsA levels.",
author = "Belin, {Michael W} and Bouchard, {C. S.} and S. Frantz and J. Chmielinska",
year = "1989",
language = "English (US)",
volume = "96",
pages = "1144--1150",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Topical cyclosporine in high-risk corneal transplants

AU - Belin, Michael W

AU - Bouchard, C. S.

AU - Frantz, S.

AU - Chmielinska, J.

PY - 1989

Y1 - 1989

N2 - Cyclosporine (cyclosporin A, CsA) is a selective T-cell immunosuppressant that works primarily through inhibition of both antigen presentation and lymphokine production. It has dramatically improved the prognosis for solid organ transplantation. Significant nephrotoxicity has been associated with its systemic use. Topical CsA 2% was used in 11 high-risk corneal transplant patients (8 men; 3 women; average age, 44 years). Ten (91%) of 11 corneas remained clear at an average follow-up of 16 months (range, 6-24 months). All patients had transient epithelial keratitis. Systemic whole blood levels of CsA measured by high-performance liquid chromatography (HPLC) ranged from 14 to 64 ng/ml. All previous reports on the use of topical CsA in high-risk corneal transplant patients have not detected systemic CsA levels.

AB - Cyclosporine (cyclosporin A, CsA) is a selective T-cell immunosuppressant that works primarily through inhibition of both antigen presentation and lymphokine production. It has dramatically improved the prognosis for solid organ transplantation. Significant nephrotoxicity has been associated with its systemic use. Topical CsA 2% was used in 11 high-risk corneal transplant patients (8 men; 3 women; average age, 44 years). Ten (91%) of 11 corneas remained clear at an average follow-up of 16 months (range, 6-24 months). All patients had transient epithelial keratitis. Systemic whole blood levels of CsA measured by high-performance liquid chromatography (HPLC) ranged from 14 to 64 ng/ml. All previous reports on the use of topical CsA in high-risk corneal transplant patients have not detected systemic CsA levels.

UR - http://www.scopus.com/inward/record.url?scp=0024371199&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024371199&partnerID=8YFLogxK

M3 - Article

C2 - 2797718

AN - SCOPUS:0024371199

VL - 96

SP - 1144

EP - 1150

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -